Analgesic Self-medication for Acute Pain by Patients Awaiting a Consultation With a General Practitioner (AAPAC)
Primary Purpose
Acute Pain
Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Questionnaire
Sponsored by
About this trial
This is an interventional other trial for Acute Pain focused on measuring acute pain, analgesics, self medication
Eligibility Criteria
Inclusion Criteria:
- adult patient
- without cognitive impairment
- having acute pain for less than 3 months
- Consultant to the practices participating to the study.
Exclusion Criteria:
- Patients who do not understand French
- Patients protected by law
Sites / Locations
- MSP HautevilleRecruiting
- MSPU bel-airRecruiting
- Maison de santé de MalissolRecruiting
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Questionnaire : Taken analgesics
Arm Description
the patient will complete a questionnaire
Outcomes
Primary Outcome Measures
Description of analgesic self-medication practices while waiting for a consultation with the general practitioner.
dose of analgesic drugs per intake and per frequency
Secondary Outcome Measures
Highlighting the reason for misuse of analgesics on an outpatient basis in the population studied while waiting for a consultation.
Incidence of.each reason for misuse as indicated in the questionnaire
Full Information
NCT ID
NCT05412407
First Posted
June 1, 2022
Last Updated
September 26, 2023
Sponsor
Hospices Civils de Lyon
1. Study Identification
Unique Protocol Identification Number
NCT05412407
Brief Title
Analgesic Self-medication for Acute Pain by Patients Awaiting a Consultation With a General Practitioner
Acronym
AAPAC
Official Title
What Are the Terms of Use of Analgesics for Acute Pain on a Patient Before a Consultation With a General Practitioner: Descriptive Epidemiological Study of Patients in General Practice in Rhône-Alpes
Study Type
Interventional
2. Study Status
Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
January 18, 2024 (Anticipated)
Primary Completion Date
February 18, 2024 (Anticipated)
Study Completion Date
February 18, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospices Civils de Lyon
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
What are the terms of use of analgesics for acute pain on an outpatient basis before a consultation with a general practitioner? Descriptive epidemiological study of patients in general practice in Rhône-Alpes
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Pain
Keywords
acute pain, analgesics, self medication
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
200 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Questionnaire : Taken analgesics
Arm Type
Other
Arm Description
the patient will complete a questionnaire
Intervention Type
Other
Intervention Name(s)
Questionnaire
Intervention Description
description of analgesic self-medication in the context of acute pain using a questionnaire evaluating the drug taken, the dosage, the duration of treatment, the type of pain, its intensity, the origin of the drug, the source of information consulted and the factors that prompted the patient to self-medicate
Primary Outcome Measure Information:
Title
Description of analgesic self-medication practices while waiting for a consultation with the general practitioner.
Description
dose of analgesic drugs per intake and per frequency
Time Frame
Inclusion
Secondary Outcome Measure Information:
Title
Highlighting the reason for misuse of analgesics on an outpatient basis in the population studied while waiting for a consultation.
Description
Incidence of.each reason for misuse as indicated in the questionnaire
Time Frame
Inclusion
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
adult patient
without cognitive impairment
having acute pain for less than 3 months
Consultant to the practices participating to the study.
Exclusion Criteria:
Patients who do not understand French
Patients protected by law
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Assad ACHIQ
Phone
+33755385765
Email
achiq.assad@hotmail.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Toufik KHAYI
Phone
+33698030629
Email
toufik.khayi@hotmail.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Assad ACHIQ
Organizational Affiliation
Médecins remplaçants
Official's Role
Principal Investigator
Facility Information:
Facility Name
MSP Hauteville
City
Hauteville-Lompnes
ZIP/Postal Code
01110
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
assad achiq
Phone
07 55 38 57 65
Email
achiq.assad@hotmail.fr
Facility Name
MSPU bel-air
City
Saint-Priest
ZIP/Postal Code
69800
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Assad ACHIQ
Phone
07 55 38 57 65
Email
achiq.assad@hotmail.fr
Facility Name
Maison de santé de Malissol
City
Vienne
ZIP/Postal Code
38200
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
assad achiq
Phone
07 55 38 57 65
Email
achiq.assad@hotmail.fr
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Analgesic Self-medication for Acute Pain by Patients Awaiting a Consultation With a General Practitioner
We'll reach out to this number within 24 hrs